LINX®

LINX® Reflux Management System changes the lives of patients with gastroesophageal reflux disease (GERD).
Linx
92%

Positive change in quality of life satis­fac­tion from 8% to 92%1

89%

89% savings from pre-to post-​intervention1

50%

50% greater savings than the stan­dard invaasive surgical proce­dure1

Value for technology leaders

According to a spokesperson from Torax Medical, LINX® has been highly effec­tive.

After getting the LINX® device:

  • 85 percent of patients were free from depen­dence on daily reflux medica­tions
  • 88 percent of patients reported no more heart­burn
  • 99 percent of patients elim­i­nated regur­gi­t­tion

Technology Leader — Torax Medical. Minnesota-​based manu­fac­turer of the LINX® system

Blair Jobe

Real Benefits for Clinicians

“LINX® is a reversible and less inva­sive outpa­tient tech­nique for surgical manage­ment of GERD and results in signif­i­cant reduc­tion of esophageal acid expo­sure, better quality of life, and less reliance on proton-​pump inhibitor therapy.”

Blair Jobe, MD – Clinical Lead
Surgeon and Director of the Esophageal and Lung Institute for Allegheny Health Network

A VITAL collaboration

Through VITAL’s collab­o­ra­tion with Torax Medical and Allegheny Health Network clin­i­cians, the novel LINX® Management System has greatly reduced the symp­toms and risks for patients who have GERD, better known as acid reflux.

People with GERD feel heart­burn, bloating, and regur­gi­ta­tion with almost every meal. Though daily medica­tions can help these symp­toms, severe acid reflux is a dangerous condi­tion, leading to pneu­monia, asthma, coughing, Barrett’s esoph­agus, dysplasia, and esophageal cancer.

According to the American Gastroenterology Association, it is esti­mated that more than 60 million Americans expe­ri­ence symp­to­matic GERD at least once a month, and 15 million suffer from it daily.

Surgeons place the LINX® device through a non-​invasive, 30 – 60 minute laparo­scopic proce­dure. It consists of tiny magnetic tita­nium beads in a ring that is placed around the area where the stomach and esoph­agus meet. Once in place, it:

  • 85 percent of patients were free from depen­dence on daily reflux medica­tions
  • 88 percent of patients reported no more heart­burn
  • 99 percent of patients elim­i­nated regur­gi­t­tion

Outcomes

Adopted as new med­ical policy as of June 2017

Publications

1Results based on VITAL projects.